Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 45272 results
Bayer closes acquisition of Merck Consumer Care for $14.2bn
By PBR Staff Writer
German pharmaceutical firm Bayer has completed the acquisition of Merck Consumer Care (MCC) business from US-based Merck for $14.2bn.
News
Takeda releases interim Phase III data supporting long-term efficacy of vedolizumab
By PBR Staff Writer
Takeda Pharmaceuticals International has reported new data from GEMINI LTS (Long-Term Safety), an ongoing, open-label extension Phase III trial of Entyvio (vedolizumab) to treat adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).
News
Quest PharmaTech, Bioceltran ink licence deal for photodynamic therapy technology
By PBR Staff Writer
Quest PharmaTech has agreed to license its photodynamic therapy (PDT) technology to South Korea-based firm Bioceltran in return for up-front license fees, milestone payments and royalties on future product sales.
News
CDC confirms first Ebola case in US
By PBR Staff Writer
The US Centers for Disease Control and Prevention (CDC) has confirmed the first case of Ebola in Dallas, Texas, US.
News
Glialogix, Fast Forward partner to support development of new multiple sclerosis treatments
By PBR Staff Writer
US-based biopharma firm Glialogix has entered into a Sponsored Research Agreement with Fast Forward, a nonprofit organization established by the National Multiple Sclerosis (MS) Society to accelerate the development of treatments for multiple sclerosis (MS).
News
FDA approves XTANDI to treat metastatic castration-resistant prostate cancer
By PBR Staff Writer
Diplomat has announced that the US Food and Drug Administration (FDA) has approved XTANDI to treat metastatic castration-resistant prostate cancer (CRPC).
News
CSL Behring expands manufacturing facility in Kankakee, US
CSL Behring announced that it is set to commence operations in its newly expanded facility now that the US Food & Drug Administration (FDA) has granted approval.
News
Cellular Biomedicine completes acquisition of Agreen Biotech
Cellular Biomedicine Group (CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, has announced it has completed the previously announced acquisition of privately held Agreen Biotech and its founder's US patent.
News
USPTO issues can-fite patent for CF102 to treat liver regeneration and function after surgery
Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has announced the US Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of liver regeneration and function following liver surgery.
News
KemPharm gets patent from USPTO for new prodrug of hydromorphone
KemPharm, a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, has announced that the United States Patent and Trademark Office (USPTO) issued US Patent No. 8,816,083 to KemPharm for its patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof."
News
KAI secures CDC contract to support annual influenza vaccine serology testing
KAI Research (KAI), a wholly owned subsidiary of Altarum Institute, announced today that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult, and elderly individuals’ serum levels after flu vaccination to determine whether antibodies induced by the current vaccine effectively inhibit circulating influenza viruses.
News
Johnson & Johnson to buy Alios BioPharma for $1.75bn
By PBR Staff Writer
Johnson & Johnson (J&J) has agreed to acquire US-based biopharmaceutical firm Alios BioPharma for about $1.75bn.
News
Inergetics launches Surgex Warrior Sports Nutrition
By PBR Staff Writer
Inergetics, a US-based developer of nutritional supplements, has launched Surgex Warrior Sports Nutrition, the preferred nutritional supplements of Army Sports.
News
Boehringer invests €100m to increase Respimat production in Dortmund
By PBR Staff Writer
German research-driven pharmaceutical firm Boehringer Ingelheim is investing more than €100m at its Dortmund site to increase the production capacity of Respimat inhaler to 44 million units per year.
News
DanDrit, San Martino Hospital to begin Phase II trials of colorectal cancer vaccine MelCancerVac
By PBR Staff Writer
Denmark-based DanDrit Biotech has entered into collaboration with the University Hospital IRCCS 'San Martino' - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa to begin a Phase III adjuvant trial of MelCancerVac in patients with no evidence of disease (NED) stage IV colorectal cancer (CRC).
News
136-150 of 45272 results